Literature DB >> 21029094

NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell death.

Ranjana Poddar1, Ishani Deb, Saibal Mukherjee, Surojit Paul.   

Abstract

The present study examines the role of a neuron-specific tyrosine phosphatase (STEP, striatal-enriched tyrosine phosphatase) in excitotoxic cell death. Our findings demonstrate that p38 MAPK, a stress-activated kinase that is known to play a role in the etiology of excitotoxic cell death is a substrate of STEP. Glutamate-mediated NMDA receptor stimulation leads to rapid but transient activation of p38 MAPK, which is primarily dependent on NR2A-NMDA receptor activation. Conversely, activation of NR2B-NMDA receptors leads to dephosphorylation and subsequent activation of STEP, which in turn leads to inactivation of p38 MAPK. Thus, during transient NMDA receptor stimulation, increases in STEP activity appears to limit the duration of activation of p38 MAPK and improves neuronal survival. However, if NR2B-NMDA receptor stimulation is sustained, protective effects of STEP activation are lost, as these stimuli cause significant degradation of active STEP, leading to secondary activation of p38 MAPK. Consistent with this observation, a cell transducible TAT-STEP peptide that constitutively binds to p38 MAPK attenuated neuronal cell death caused by sustained NMDA receptor stimulation. The findings imply that the activation and levels of STEP are dependent on the duration and magnitude of NR2B-NMDA receptor stimulation and STEP serves as a modulator of NMDA receptor dependent neuronal injury, through its regulation of p38 MAPK.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029094      PMCID: PMC3035421          DOI: 10.1111/j.1471-4159.2010.07035.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  59 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death.

Authors:  P K Mukherjee; M A DeCoster; F Z Campbell; R J Davis; N G Bazan
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

3.  NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling.

Authors:  Surojit Paul; Angus C Nairn; Ping Wang; Paul J Lombroso
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

4.  Regulation of the cyclooxygenase-2 system by interleukin-1beta through mitogen-activated protein kinase signaling pathways: a comparative study of human neuroglioma and neuroblastoma cells.

Authors:  Anju S Moolwaney; Orisa J Igwe
Journal:  Brain Res Mol Brain Res       Date:  2005-04-15

5.  Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking.

Authors:  Myung Jong Kim; Anthone W Dunah; Yu Tian Wang; Morgan Sheng
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

6.  Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.

Authors:  E Rundén; P O Seglen; F M Haug; O P Ottersen; T Wieloch; M Shamloo; J H Laake
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro.

Authors:  K R Tovar; G L Westbrook
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors.

Authors:  M C Grabb; D W Choi
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

9.  PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.

Authors:  R Pulido; A Zúñiga; A Ullrich
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

10.  The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death.

Authors:  Jiong Cao; Jenni I Viholainen; Caroline Dart; Helen K Warwick; Mark L Leyland; Michael J Courtney
Journal:  J Cell Biol       Date:  2005-01-03       Impact factor: 10.539

View more
  31 in total

1.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

2.  Oxidative stress-induced oligomerization inhibits the activity of the non-receptor tyrosine phosphatase STEP61.

Authors:  Ishani Deb; Ranjana Poddar; Surojit Paul
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

Review 3.  Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.

Authors:  Jian Xu; Pradeep Kurup; Angus C Nairn; Paul J Lombroso
Journal:  Adv Pharmacol       Date:  2012

4.  Molecular mechanism of ERK dephosphorylation by striatal-enriched protein tyrosine phosphatase.

Authors:  Rong Li; Di-Dong Xie; Jun-Hong Dong; Hui Li; Kang-Shuai Li; Jing Su; Lai-Zhong Chen; Yun-Fei Xu; Hong-Mei Wang; Zheng Gong; Guo-Ying Cui; Xiao Yu; Kai Wang; Wei Yao; Tao Xin; Min-Yong Li; Kun-Hong Xiao; Xiao-Fei An; Yuqing Huo; Zhi-Gang Xu; Jin-Peng Sun; Qi Pang
Journal:  J Neurochem       Date:  2013-10-31       Impact factor: 5.372

5.  Microglia Adopt Longitudinal Transcriptional Changes After Traumatic Brain Injury.

Authors:  Hadijat M Makinde; Talia B Just; Gaurav T Gadhvi; Deborah R Winter; Steven J Schwulst
Journal:  J Surg Res       Date:  2019-09-26       Impact factor: 2.192

6.  Aging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP.

Authors:  Sathyanarayanan Rajagopal; Ishani Deb; Ranjana Poddar; Surojit Paul
Journal:  Neurobiol Aging       Date:  2016-02-12       Impact factor: 4.673

7.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

8.  Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.

Authors:  Clare M Gladding; Jing Fan; Lily Y J Zhang; Liang Wang; Jian Xu; Edward H Y Li; Paul J Lombroso; Lynn A Raymond
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

9.  Zn2+-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP: MOLECULAR BASIS FOR ZN2+-INDUCED ERK MAPK ACTIVATION.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; C William Shuttleworth; Surojit Paul
Journal:  J Biol Chem       Date:  2015-11-16       Impact factor: 5.157

10.  Transcriptomic Profiling of Medial Temporal Lobe Epilepsy.

Authors:  Abhilash K Venugopal; Ghantasala S Sameer Kumar; Anita Mahadevan; Lakshmi Dhevi N Selvan; Arivusudar Marimuthu; Jyoti Bajpai Dikshit; Pramila Tata; Yl Ramachandra; Raghothama Chaerkady; Sanjib Sinha; Ba Chandramouli; A Arivazhagan; Parthasarathy Satishchandra; Sk Shankar; Akhilesh Pandey
Journal:  J Proteomics Bioinform       Date:  2012-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.